Additional to the batches included in the previous Class 4 Medicines Notification from 16th November 2022. Martindale Pharma has made the MHRA aware that the GTIN in the 2D barcode and the printed variable data represents the branded version of the product (Venlalic® XL prolonged-release tablets). It should instead reflect the generic name: Venlafaxine XL prolonged-release tablets. The code under the pre-printed barcode is correct.
Further information can be found on the MHRA website.